Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 410 publications
International Myeloma Working Group Recommendations for the Diagnosis and Management of Solitary Plasmacytomas.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 22, 2026
Efficacy and safety of durcabtagene autoleucel in a phase 1 trial for patients with relapsed/refractory multiple myeloma.
Journal: Science translational medicine
Published: May 27, 2026
The International Myeloma Society Honors the Life and Legacy of Myeloma Pioneer Brian G. M. Durie, MD, PhD (1942-2025).
Journal: Clinical lymphoma, myeloma & leukemia
Published: May 08, 2026
The role of RAD23A in DNA repair and proteasome-dependent protein degradation in multiple myeloma.
Journal: Blood cancer journal
Published: April 09, 2026
Ciltacabtagene autoleucel in high-risk smoldering multiple myeloma: the CAR-PRISM phase 2 trial.
Journal: Nature medicine
Published: March 13, 2026
PKMYT1 is a Targetable Vulnerability in del(17p) High-Risk Multiple Myeloma.
Journal: Blood
Published: February 25, 2026
Mechanistically Defined Epoxide- and Aziridine-2-carboxamide Electrophiles Enable Stereoselective Covalent RNA Modulation.
Journal: bioRxiv : the preprint server for biology
Published: February 06, 2026
Evolution of Real-World Front-Line Treatment Patterns in Multiple Myeloma.
Journal: Blood advances
Published: January 30, 2026
WNK2 oncogenicity revealed by the discovery and functional characterization of novel gene isoforms in MYD88 mutated Waldenström's Macroglobulinemia.
Journal: Blood cancer journal
Published: January 20, 2026
Last Updated: 09/26/2026